UK-based Alchemab Therapeutics, a biopharma seeking to identify and develop naturally occurring therapeutic antibodies from ...

UK headquartered Verdiva Bio Limited today announced its launch as a clinical-stage biopharmaceutical company focused on ...

Italy-based Newron Pharmaceuticals (SIX: NWRN, XETRA: NP5), a biopharma developing therapies for diseases of the central and ...

Cambridge, USA-based biotech Sunbird Bio, which is developing proprietary blood-based technologies to improve diagnosis and ...

AstraZeneca's Lynparza receives NICE approval for treating advanced breast cancer in England and Wales, backed by OlympiAD ...

German family-owned pain focused drugmaker Grünenthal announced today that Prof Dr Uli Brödl will assume the role of chief ...

MaaT Pharma reports positive Phase III results for MaaT013, its microbiome-based therapy for gastrointestinal GvHD, achieving ...

AiCuris appoints Jacques Dumas as CSO to lead research efforts as the company refocuses on infectious disease therapies for ...

Angelini Ventures co-leads a $21 million series A round for Neumirna Therapeutics, supporting its RNA-based therapies for ...

Insilico Medicine raises over $100 million in series E funding to advance AI-driven drug discovery, including ISM001-055, the ...

Canadian biotech Aspect Biosystems, which is developing bioprinted tissue therapeutics as a new category in regenerative ...

Calico Life Sciences, a biotech founded by Alphabet and Arthur Levinson focused on the biology of aging and age-related ...